Villa Medical Center Phuket (www.thailandstemcell.com), a regional pioneer in regenerative medicine and advanced cell therapies, has strengthened its scientific oversight by launching an extensive stem cell quality testing initiative in partnership with the Thailand Institute of Scientific and Technological Research (TISTR). This collaboration centers around key cellular quality attributes—morphological integrity, viable cell count, contamination-free purity, and DNA stability via the Comet Assay method.
This collaboration underscores Villa Medical Center Phuket’ systematic approach to ensuring high standards in Quality Assurance (QA) and Quality Control (QC), reinforcing the company’s clinical-grade production workflows. These quality benchmarks are foundational for ensuring that all therapeutic-grade stem cell lines meet stringent safety and performance criteria suitable for international application in regenerative medicine and ATMP (Advanced Therapy Medicinal Products).
Comprehensive Quality Metrics for Clinical-Grade Stem Cells
Stem cells are central to regenerative medicine due to their ability to modulate immune responses, promote tissue regeneration, and differentiate into various cell types. Ensuring their therapeutic effectiveness requires rigorous testing of viability, morphology, genetic stability, and microbial safety.
Villa Medical Center Phuket and TISTR jointly undertake the following assessments to validate each production batch:
1. Morphology Profiling
Using phase-contrast microscopy, Atlantis assesses the morphology of mesenchymal stem cells (MSCs), favoring the spindle-shaped, fibroblast-like morphology known to indicate high cellular health and replicative capacity. Deviations in morphology can suggest underlying issues such as senescence or contamination.
2. Cell Count and Viability
Accurate quantification of viable cells is a clinical necessity. Atlantis employs standardized counting methods, including trypan blue exclusion and automated cell counters, while TISTR validates expansion efficiency and yield consistency, guaranteeing therapeutic-level dosing.
3. Microbial Contamination Testing
Ensuring sterility is non-negotiable in stem cell therapy. Atlantis conducts bacterial and fungal testing using culture and molecular assays in line with international quality protocols. TISTR independently verifies that every lot is contamination-free before clinical release.
4. Genetic Stability via Comet Assay
The Comet Assay enables detection of DNA fragmentation at the individual cell level, a vital measure of genetic integrity. Excessive DNA damage can reduce therapeutic potency and increase oncogenic risk. By integrating Comet Assay into routine QC, Atlantis ensures the genomic integrity of its MSCs.
Commitment to International GMP and ISO Standards
Villa Medical Center Phuket aligns its entire production workflow with GMP and ISO-compliant practices. This includes validated cryopreservation, certified reagents, and complete documentation for traceability. Each phase—from isolation to infusion—is governed by strict QA frameworks, with TISTR acting as a trusted third-party verifier.
Clinical Impact of High-Quality MSCs
Atlantis stem cells are deployed across a wide array of clinical fields:
– Orthopedics: Joint regeneration, ligament healing, and spinal disc repair
– Dermatology and Aesthetics: Scar reduction, anti-aging skin therapies, and hair growth
– Dental Regeneration: Periodontal healing and maxillofacial tissue reconstruction
– Immunotherapy: Treatment of autoimmune diseases and inflammatory conditions
– Research & Trials: Gene-modified stem cells for cancer and neurodegeneration
The success of these applications hinges on uncompromised cell quality—something Atlantis ensures through its TISTR-validated pipeline.
Thailand’s Strategic Role in Regenerative Medicine
Thailand’s life sciences ecosystem continues to rise as a regional leader in regenerative therapies. Organizations like TISTR provide scientific credibility and testing infrastructure to bring locally produced biologics to global standards. Atlantis’ engagement with TISTR is part of its broader mission to integrate advanced testing, research collaboration, and clinical application within Thailand’s biomedical landscape.
This public-private partnership model strengthens the regulatory and scientific backbone needed for scalable, ethical, and internationally relevant stem cell applications.
The Future of Regenerative Care Is Rooted in Quality
As cell-based therapies move toward mainstream adoption, the field’s credibility relies on robust quality systems. Atlantis Medical Services exemplifies this standard, with its dual commitment to scientific transparency and patient safety. By embracing gold-standard methodologies such as the Comet Assay and collaborating with established research institutions, Atlantis paves the way for ethical innovation in stem cell therapy.
Stem cell therapies must meet rigorous standards for purity, potency, and genetic integrity to earn global trust. With its partnership with TISTR, Atlantis Medical Services sets a benchmark for regenerative clinics and laboratories not just in Thailand—but throughout the Asia-Pacific region.
Villa Medical Center Phuket
Villa Sukhothai, Soi Pasak 8, Choeng Thale,
Thalang District, Phuket, Thailand
Email: atlantisphuket@gmail.com
Phone/WhatsApp: +66 99 301 6969